These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 543572)

  • 1. Retrospective DNA analyses in cervical dysplasia as related to neoplastic progression or regression.
    Nasiell K; Auer G; Nasiell M; Zetterberg A
    Anal Quant Cytol; 1979; 1(2):103-6. PubMed ID: 543572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation patterns of cervical cells as visualized in Leiden liquid cytology slides.
    Luzzatto L; van Haaften C; Boon ME
    Diagn Cytopathol; 2004 Jul; 31(1):5-9. PubMed ID: 15236256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [DNA content and prognosis in atypical cervix epithelium].
    Bergleiter R
    Zentralbl Gynakol; 1986; 108(19):1164-9. PubMed ID: 3811665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomorphologic and cytochemical analysis in the differential diagnosis of cervical epithelial lesions.
    Nasiell K; Näslund I; Auer G
    Anal Quant Cytol; 1984 Sep; 6(3):196-200. PubMed ID: 6508037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microphotometric nuclear DNA analysis in cervical dysplasia of the uterine cervix: its relation to the progression to malignancy and regression to normalcy.
    Kashyap V; Das DK; Luthra UK
    Neoplasma; 1990; 37(5):497-500. PubMed ID: 2234211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-cytometric diagnosis of prospective malignancy in borderline lesions of the uterine cervix.
    Böcking A; Hilgarth M; Auffermann W; Hack-Werdier C; Fischer-Becker D; von Kalkreuth G
    Acta Cytol; 1986; 30(6):608-15. PubMed ID: 3466496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
    Khaled A; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
    Singh M; Prasad S; Kalra N; Singh U; Shukla Y
    Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of severe dysplasia and carcinoma in situ detected by directed biopsy].
    Milojković M; Makarović Z; Pajtler M
    Jugosl Ginekol Perinatol; 1989; 29(5-6):198-200. PubMed ID: 2640269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytomorphologic and morphometric characteristics of the endocervical epithelium during malignant degeneration].
    Novik VI; Agroskin LS; Solov'eva LV
    Vopr Onkol; 1989; 35(6):715-21. PubMed ID: 2750084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Apoptosis and cell growth fraction in normal, dysplastic and neoplastic squamous epithelium of uterine cervix].
    Furuya H; Yabushita H; Noguchi M; Nakanishi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):141-8. PubMed ID: 7706854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exfoliative immunocytology of cervical carcinoma.
    Efthymiou CJ; Smulewicz JJ
    Arch Pathol Lab Med; 1977 Nov; 101(11):575-8. PubMed ID: 334107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear DNA content and the number of Barr bodies in premalignant and malignant lesions of the uterine cervix.
    Nishiya I; Ishizaki Y; Sasaki M
    Acta Cytol; 1981; 25(4):407-11. PubMed ID: 6945007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papanicolaou test and enzyme-linked in-situ hybridization. A combined diagnostic system for papilloma virus infections with high prognostic value.
    Schön HJ; Czerwenka KF; Schurz B; Kramar R; Kubista E
    Eur J Clin Chem Clin Biochem; 1991 Feb; 29(2):131-8. PubMed ID: 1646654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LA-1 oncogene. A possible new prognostic index for evaluating cervical squamous intraepithelial lesions.
    Sainz de la Cuesta R; Reed TP; Brothman JC; Dubin NH
    J Reprod Med; 1993 Mar; 38(3):173-8. PubMed ID: 8487232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False-negative Papanicolaou smears from women with cancerous and precancerous lesions of the uterine cervix.
    Pairwuti S
    Acta Cytol; 1991; 35(1):40-6. PubMed ID: 1994633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colposcopic management of abnormal cervical cytology in pregnancy.
    LaPolla JP; O'Neill C; Wetrich D
    J Reprod Med; 1988 Mar; 33(3):301-6. PubMed ID: 3361522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphology and DNA content of cultures from normal and dysplastic epithelium, carcinoma in situ and carcinomas of the cervix uteri (author's transl)].
    Ebeling K; Krug H; Bilek K
    Arch Geschwulstforsch; 1978; 48(1):17-34. PubMed ID: 655777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of phenotypic cytologic characteristics in early dysplastic cervical lesions.
    Schlaen I; Gonzalez Garcia MR; Weismann EA
    Acta Cytol; 1988; 32(3):298-302. PubMed ID: 3287818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.